dalteparin sodium
Term · Oncology and biomedicine · MLC-T-ONC-002274
A drug used to prevent blood clots from forming or to treat blood clots that have formed in patients with cancer or other conditions. Dalteparin sodium is a type of anticoagulant. Also called Fragmin.
The sodium salt of a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, dalteparin binds to antithrombin and enhances the inhibition of Factor Xa. Compared to unfractionated heparins, the use of dalteparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia.
| Identifier | MLC-T-ONC-002274 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Fragmin |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-002274",
"term": "dalteparin sodium",
"field": "Oncology and biomedicine",
"definitions": [
"A drug used to prevent blood clots from forming or to treat blood clots that have formed in patients with cancer or other conditions. Dalteparin sodium is a type of anticoagulant. Also called Fragmin.",
"The sodium salt of a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, dalteparin binds to antithrombin and enhances the inhibition of Factor Xa. Compared to unfractionated heparins, the use of dalteparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia."
],
"synonyms": [
"Fragmin"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dalteparin-sodium/"
}
Record 5,672 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.